Cowen And Company, LLC Tarsus Pharmaceuticals, Inc. Transaction History
Cowen And Company, LLC
- $3.91 Billion
- Q2 2024
A detailed history of Cowen And Company, LLC transactions in Tarsus Pharmaceuticals, Inc. stock. As of the latest transaction made, Cowen And Company, LLC holds 2,197,385 shares of TARS stock, worth $69.9 Million. This represents 1.53% of its overall portfolio holdings.
Number of Shares
2,197,385
Previous 2,122,530
3.53%
Holding current value
$69.9 Million
Previous $77.2 Million
22.59%
% of portfolio
1.53%
Previous 2.59%
Shares
8 transactions
Others Institutions Holding TARS
# of Institutions
155Shares Held
40.4MCall Options Held
37.9KPut Options Held
808K-
Rtw Investments, LP New York, NY3.41MShares$109 Million1.55% of portfolio
-
Black Rock Inc. New York, NY3.27MShares$104 Million0.0% of portfolio
-
Paradigm Biocapital Advisors LP New York, NY2.44MShares$77.4 Million2.68% of portfolio
-
Tang Capital Management LLC San Diego, CA2.25MShares$71.7 Million7.48% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.99MShares$63.3 Million0.0% of portfolio
About Tarsus Pharmaceuticals, Inc.
- Ticker TARS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,658,500
- Market Cap $848M
- Description
- Tarsus Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of novel therapeutic candidates for ophthalmic conditions. Its lead product candidate is TP-03, a novel therapeutic that is in Phase III for the treatment of blepharitis caused by the infestation of Demodex mites, as well as...